COVID-19 (SARS-CoV-2) variants
Information on variants of the SARS-CoV-2 virus.
Data
Guidance and information
Investigation of SARS-CoV-2 variants
COVID-19 therapeutics
Lateral flow testing
News and announcements
NERVTAG statements on COVID-19 (SARS-CoV-2) (updated regularly)
Surge testing
Updates to this page
Published 21 December 2020Last updated 21 January 2022 + show all updates
-
Added 'COVID-19 therapeutic agents: technical briefings'.
-
Added 'SARS-CoV-2 variant of concern diagnostic assurance' and 'Reflex (genotyping) assays for identification of priority SARS-CoV-2 variants of concern'.
-
Added 'SARS-CoV-2 variants of public health interest' under 'Investigation of SARS-CoV-2 variants'.
-
Added link to 'Increased household transmission of COVID-19 cases associated with SARS-CoV-2 Variant of Concern B.1.617.2: a national case-control study'.
-
Added links to 'Confirmed cases of VOC-21APR-02 by week' under Data.
-
Added 'Investigation of SARS-CoV-2 variants' section.
-
Added 'COVID-19 surge testing outcomes reports: management information' under Surge testing.
-
Added Data and Surge testing sections.
-
Added link to 'SARS-CoV-2 lateral flow antigen tests: evaluation of VOC1 (Kent, UK) and VOC2 (South Africa)' guidance.
-
Added 'COVID-19 variants: genomically confirmed case numbers'.
-
Added 'SARS-CoV-2 VOC: investigating and managing individuals with a possible or confirmed case'.
-
Added link to New variant clustering in households analysis (ONS).
-
Added link to Central Alerting System (CAS) alert under 'Guidance and information'.
-
Added links to news stories.
-
Added 'SARS-CoV-2 lateral flow antigen tests: evaluation of VUI-202012/01'.
-
First published.